Gupta P, Barak S, Feuermann Y, Goobes G, Kaphzan H
Mol Autism. 2024; 15(1):31.
PMID: 39049050
PMC: 11267930.
DOI: 10.1186/s13229-024-00608-2.
Carriero P, Zangari R, Sfreddo E, Ghirardi A, Schieppati A, Barbui T
J Clin Med. 2024; 13(12).
PMID: 38930051
PMC: 11204522.
DOI: 10.3390/jcm13123520.
Hwang H, Yamashita S, Matsumoto Y, Ito M, Edwards A, Sasaki J
Mol Psychiatry. 2024; 29(11):3364-3380.
PMID: 38734844
PMC: 11541007.
DOI: 10.1038/s41380-024-02586-6.
Qu S, Wang J, Guan X, Song C, Wang Y
Orphanet J Rare Dis. 2024; 19(1):146.
PMID: 38580983
PMC: 10996173.
DOI: 10.1186/s13023-024-03154-5.
Cording K, Bateup H
Front Cell Neurosci. 2023; 17:1270489.
PMID: 38026686
PMC: 10663323.
DOI: 10.3389/fncel.2023.1270489.
Stem cell models of Angelman syndrome.
Camoes Dos Santos J, Appleton C, Cazaux Mateus F, Covas R, Bekman E, da Rocha S
Front Cell Dev Biol. 2023; 11:1274040.
PMID: 37928900
PMC: 10620611.
DOI: 10.3389/fcell.2023.1274040.
Emerging concepts involving inhibitory and activating RNA functionalization towards the understanding of microcephaly phenotypes and brain diseases in humans.
Tokunaga M, Imamura T
Front Cell Dev Biol. 2023; 11:1168072.
PMID: 37408531
PMC: 10318543.
DOI: 10.3389/fcell.2023.1168072.
Imbalanced expression of cation-chloride cotransporters as a potential therapeutic target in an Angelman syndrome mouse model.
Egawa K, Watanabe M, Shiraishi H, Sato D, Takahashi Y, Nishio S
Sci Rep. 2023; 13(1):5685.
PMID: 37069177
PMC: 10110603.
DOI: 10.1038/s41598-023-32376-z.
Linoleic acid improves PIEZO2 dysfunction in a mouse model of Angelman Syndrome.
Romero L, Caires R, Victor A, Ramirez J, Sierra-Valdez F, Walsh P
Nat Commun. 2023; 14(1):1167.
PMID: 36859399
PMC: 9977963.
DOI: 10.1038/s41467-023-36818-0.
Clocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures.
Sun S, Wang H
Int J Mol Sci. 2023; 24(4).
PMID: 36835631
PMC: 9962262.
DOI: 10.3390/ijms24044223.
Excessive Protein Accumulation and Impaired Autophagy in the Hippocampus of Angelman Syndrome Modeled in Mice.
Aria F, Pandey K, Alberini C
Biol Psychiatry. 2023; 94(1):68-83.
PMID: 36764852
PMC: 10276539.
DOI: 10.1016/j.biopsych.2022.11.016.
Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome.
Lee D, Chen W, Kaku H, Zhuo X, Chao E, Soriano A
Elife. 2023; 12.
PMID: 36594817
PMC: 9904759.
DOI: 10.7554/eLife.81892.
Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Gene.
Syding L, Kubik-Zahorodna A, Nickl P, Novosadova V, Kopkanova J, Kasparek P
Cells. 2022; 11(18).
PMID: 36139390
PMC: 9496699.
DOI: 10.3390/cells11182815.
The contribution of imprinted genes to neurodevelopmental and neuropsychiatric disorders.
Isles A
Transl Psychiatry. 2022; 12(1):210.
PMID: 35597773
PMC: 9124202.
DOI: 10.1038/s41398-022-01972-4.
Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models of Cdkl5 deficiency.
Adhikari A, Buchanan F, Fenton T, Cameron D, Halmai J, Copping N
Hum Mol Genet. 2022; 31(18):3032-3050.
PMID: 35445702
PMC: 9476626.
DOI: 10.1093/hmg/ddac091.
The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models.
Mapelli L, Soda T, DAngelo E, Prestori F
Int J Mol Sci. 2022; 23(7).
PMID: 35409253
PMC: 8998980.
DOI: 10.3390/ijms23073894.
Gait as a quantitative translational outcome measure in Angelman syndrome.
Petkova S, Adhikari A, Berg E, Fenton T, Duis J, Silverman J
Autism Res. 2022; 15(5):821-833.
PMID: 35274462
PMC: 9311146.
DOI: 10.1002/aur.2697.
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.
Copping N, McTighe S, Fink K, Silverman J
Neurotherapeutics. 2021; 18(3):1535-1547.
PMID: 34528170
PMC: 8608975.
DOI: 10.1007/s13311-021-01082-x.
Electrophysiological Characterization of Regular and Burst Firing Pyramidal Neurons of the Dorsal Subiculum in an Angelman Syndrome Mouse Model.
Rayi P, Kaphzan H
Front Cell Neurosci. 2021; 15:670998.
PMID: 34512263
PMC: 8427506.
DOI: 10.3389/fncel.2021.670998.
Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A Receptor Blockade.
Moreira-de-Sa A, Goncalves F, Lopes J, Silva H, Tome A, Cunha R
Mol Neurobiol. 2021; 58(6):2543-2557.
PMID: 33464534
DOI: 10.1007/s12035-020-02275-9.